Adenocarcinoma of the cervix and vagina in pediatric patients

Pediatric Blood and Cancer

Volumn 43, Issue 3, 2004, Pages 289-294

  McNall, René Y ^a,b   Nowicki, Philip D ^a   Miller, Brigitte ^c,d   Billups, Catherine A ^a   Liu, Tiebin ^a   Daw, Najat C ^a,b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinorna; Cervix; Children; Clear cell adenocarcinoma; Mesonephric adenocarcinoma; Vagina

Indexed keywords

DIETHYLSTILBESTROL;

ADENOCARCINOMA; ADOLESCENT; ADULT; ARTICLE; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; INFANT; MESONEPHROMA; OUTCOMES RESEARCH; PAPANICOLAOU TEST; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR RECURRENCE; UTERINE CERVIX CARCINOMA; VAGINA BLEEDING; VAGINA CARCINOMA;

ADENOCARCINOMA; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; NEOPLASM METASTASIS; PROGNOSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS;

EID: 3543139567     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20113     Document Type: Article

References (37)

1. Shepherd J, Sideri M, Benedet J, et al. Carcinoma of the vagina. J Epidemiol Biostat 1998;3:103-109.
2. Benedet J, Odicino F, Maisonneuve P, et al. Carcinoma of the cervix uteri. J Epidemiol Biostat 1998;3:5-34.
3. Hart WR. Symposium part II: Special types of adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2002;21:327-346.
4. Armed Forces Institute of Pathology. Tumors of the cervix, vagina, and vulva (Atlas of tumor pathology). Washington, DC: Armed Forces Institute of Pathology; 1992.
5. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-881.
6. Herbst AL, Robboy SJ, Scully RE, et al. Clear-cell adenocarcinoma of the vagina and cervix in girls: Analysis of 170 registry cases. Am J Obstet Gynecol 1974;119:713-724.
7. Novak E, Woodruff JD, Novak ER. Probable mesonephric origin of certain female genital tumors. Am J Obstet Gynecol 1954;68:1222-1242.
8. Studdiford W. Vaginal lesions of adenomatous origin. Am J Obstet Gynecol 1957;73:641-655.
9. Villasanta U. Tumors of mesonephric origin in the female genital tract. Am J Obstet Gynecol 1964;89:680-690.
10. Nix HG, Wright HL. Mesonephric adenocarcinoma of the vagina. Am J Obstet Gynecol 1967;99:893-899.
11. Droegemueller W, Makowski EL, Taylor ES. Vaginal mesonephric adenocarcinoma in two prepubertal children. Am J Dis Child 1970;119:168-170.
12. Siegel HA, Sagerman R, Berdon WE, et al. Mesonephric adenocarcinoma of the vagina in a 7-month-old infant simulating sarcoma botryoides. Successful control with supervoltage radiotherapy. J Pediatr Surg 1970;5:468-470.
13. Tsukada Y, Hewett WJ, Barlow JJ, et al. Clear-cell adenocarcinoma ("mesonephroma") of the vagina. 3 cases associated with maternal synthetic nonsteroid estrogen therapy. Cancer 1972;29:1208-1214.
14. Williams RR, Schweitzer RJ. Clear-cell adenocarcinoma of the vagina in a girl whose mother had taken diethylstilbestrol. Calif Med 1973;118:53-55.
15. Rosati LA, Jarzynski DJ. Clear cell (mesonephric) adenocarcinoma of the vagina. A case report. Acta Cytol 1973;17:493-497.
16. Kantor HI, Weinstein SA, Kaye HL. Clear cell adenocarcinoma in young women. Obstet Gynecol 1973;41:443-446.
17. Gilson MD, Dibona DD, Knab DR. Clear cell adenocarcinoma in young females. Obstet Gynecol 1973;41:494-500.
18. Kaminski PF, Maier RC. Clear cell adenocarcinoma of the cervix unrelated to diethylstilbestrol exposure. Obstet Gynecol 1983;62:720-727.
19. Gupta OP, Guirguis MN, Diejomaoh F. Mesonephric adenocarcinoma of cervix: A case report. Int J Gynaecol Obstet 1988;26:137-140.
20. Jones WB, Koulos JP, Saigo PE, et al. Clear-cell adenocarcinoma of the lower genital tract: Memorial Hospital 1974-1984. Obstet Gynecol 1987;70:573-577.
21. Stalens JP, Maton P, Gosseye S, et al. Hemihypertrophy, bilateral Wilms' tumor, and clear-cell adenocarcinoma of the uterine cervix in a young girl. Med Pediatr Oncol 1993;21:671-675.
22. Burks RT, Schwartz AM, Wheeler JE, et al. Late recurrence of clear-cell adenocarcinoma of the cervix: Case report. Obstet Gynecol 1990;76:525-527.
23. Jones WB, Tan LK, Lewis JL, Jr. Late recurrence of clear cell adenocarcinoma of the vagina and cervix: A report of three cases. Gynecol Oncol 1993;51:266-271.
24. Ott MM, Rehn M, Muller JG, et al. Vaginal clear cell carcinoma in a young patient with ectopic termination of the left ureter in the vagina. Virchows Arch 1994;425:445-448.
25. Tanaka H, Tabata T, Yanase H, et al. Clear cell adenocarcinoma of the vagina in a young female, treated by combination chemotherapy (local and systemic chemotherapy), complicated with chromosomal abnormality. Gynecol Oncol 1994;55:259-264.
26. Yavuz H, Arslan A, Avsaz AF. Vaginal clear cell adenocarcinoma in an infant. Pediatr Hematol Oncol 1996;13:577-580.
27. Donnelly LF, Gylys-Morin VM, Warner BW, et al. Case report: Clear cell adenocarcinoma of the vagina in a 5-year-old girl: Imaging findings. Clin Radiol 1998;53:69-72.
28. Ferry JA, Scully RE. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. Am J Surg Pathol 1990;14:1100-1111.
29. Clement PB, Young RH, Keh P, et al. Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component. Am J Surg Pathol 1995;19:1158-1171.
30. Silver SA, Devouassoux-Shisheboran M, Mezzetti TP, et al. Mesonephric adenocarcinomas of the uterine cervix: A study of 11 cases with immunohistochemical findings. Am J Surg Pathol 2001;25:379-387.
31. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer 1977;35:1-39.
32. Herbst AL. Clear cell adenocarcinoma and the current status of DES-exposed females. Cancer 1981;48:484-488.
33. Senekjian EK, Frey KW, Anderson D, et al. Local therapy in stage I clear cell adenocarcinoma of the vagina. Cancer 1987;60:1319-1324.
34. Senekjian EK, Frey KW, Stone C, et al. An evaluation of stage II vaginal clear cell adenocarcinoma according to substages. Gynecol Oncol 1988;31:56-64.
35. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153.
36. Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, et al. A phase II study of multimodality treatment for locally advanced cervical cancer: Neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 2003;14:1278-1284.
37. Fishman DA, Williams S, Small W, Jr., et al. Late recurrences of vaginal clear cell adenocarcinoma. Gynecol Oncol 1996;62:128-132.